Supernus Pharmaceuticals (SUPN) CEO, Jack Khattar on Q1 2019 Results - Earnings Call Transcript

Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) Q1 2019 Earnings Conference Call May 8, 2019 9:00 AM ET

Company Participants

Jack Khattar - President, Chief Executive Officer
Greg Patrick - Chief Financial Officer
Peter Vozzo - Investor Relations

Conference Call Participants

Ken Cacciatore - Cowen & Co.
David Steinberg - Jefferies
Nick Rubino - Stifel
Patrick Trucchio - Berenberg Capital
Mick Ingerman - Piper Jaffray
Esther Hong - Janney

Operator

Good morning ladies and gentlemen and welcome to the Supernus Pharmaceuticals First Quarter 2019 Financial Results conference call. At this time, all participants are in a listen-only mode. Later we will conduct a question and answer session and instructions will follow at that time. As a reminder, this conference call is being recorded.

I would like to turn the conference over to Peter Vozzo of Westwood Partners, Investor Relations for Supernus Pharmaceuticals. You may begin.

Peter Vozzo

Thank you, Michelle. Good morning everyone and thank you for joining us today for Supernus Pharmaceuticals first quarter 2019 financial results conference call. Yesterday after the close of the market, the company issued a press release announcing these results. On the call with me today are Supernus’ Chief Executive Officer, Jack Khattar; and Chief Financial Officer, Greg Patrick. Today’s call is being made available via the Investor Relations section of the company’s website at ir.supernus.com. Following remarks by management, we will open the call to questions.

During the course of this call, management may make certain forward-looking statements regarding the future events and the company’s future performance. These forward-looking statements reflect Supernus’ current perspective on existing trends and information and can be identified by such words as expect, plan, will, may, anticipate, believes, should, intend, and other words of similar meaning. Any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, including those noted in the Risk Factors section of our 2018 annual report